Targeting drug resistant colorectal cancer with apigenin nanoarchitectures
Drug resistance remains a critical obstacle in the treatment of colorectal cancer (CRC), contributing to high mortality rates, particularly in advanced stages. Conventional therapies, including surgery, chemotherapy, and targeted drugs, often face limitations such as systemic toxicity, poor drug sel...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332500186X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|